GlassScriptPhysician profile
Joy Amaechi
NPI 1548719834
$578.51
in general payments reported to CMS, 2019-2025
13 companies · $43.47 in 2025
The $43.47 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $39.62 · 2023: $171 · 2024: $325 · 2025: $43.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $121.86 | 2024 | Airsupra |
| Novo Nordisk INC | $99.15 | 2023-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $87.36 | 2023-2025 | Mounjaro, Jardiance |
| Abbott Laboratories | $66.04 | 2024 | Freestyle Libre 3 |
| Dexcom, INC. | $41.11 | 2023-2024 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $28.44 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $26.66 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $25.40 | 2022 | |
| Medtronic, INC. | $21.12 | 2025 | Inceptiv |
| Bayer Healthcare Pharmaceuticals INC. | $19.19 | 2023 | |
| Azurity Pharmaceuticals, INC. | $14.61 | 2023 | Horizant |
| Biohaven Pharmaceutical Holding Company LTD. | $14.22 | 2022 | |
| Amgen INC. | $13.35 | 2023 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Amaechi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.